Date: 2014-08-07
Type of information: Development agreement
Compound: tissue-based companion diagnostic tests
Company: BMS (USA - NY) Leica Biosystems (Germany)
Therapeutic area: undisclosed
Type agreement: development agreement
Action mechanism:
Disease: undisclosed
Details: * On August 7, 2014, Leica Biosystems announced an agreement with BMS to collaborate on developing fully automated tissue-based companion diagnostic tests to run on the Leica BOND automated advanced staining system for use as an aid in selecting patients for treatment with certain pharmaceuticals developed, or to be developed, by BMS. Other terms of the agreement were not disclosed.
Financial terms:
Latest news:
